A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkers.

Nature Communications
Jonathan D MosleyDan M Roden

Abstract

Defining the full spectrum of human disease associated with a biomarker is necessary to advance the biomarker into clinical practice. We hypothesize that associating biomarker measurements with electronic health record (EHR) populations based on shared genetic architectures would establish the clinical epidemiology of the biomarker. We use Bayesian sparse linear mixed modeling to calculate SNP weightings for 53 biomarkers from the Atherosclerosis Risk in Communities study. We use the SNP weightings to computed predicted biomarker values in an EHR population and test associations with 1139 diagnoses. Here we report 116 associations meeting a Bonferroni level of significance. A false discovery rate (FDR)-based significance threshold reveals more known and undescribed associations across a broad range of biomarkers, including biometric measures, plasma proteins and metabolites, functional assays, and behaviors. We confirm an inverse association between LDL-cholesterol level and septicemia risk in an independent epidemiological cohort. This approach efficiently discovers biomarker-disease associations.

References

Jan 1, 1989·British Journal of Haematology·C JernS Jern
Jul 9, 1994·Lancet·P K Whelton
Oct 6, 1998·Annual Review of Biochemistry·J E Sadler
Jul 21, 2001·Journal of Human Hypertension·A MakinD G Beevers
Apr 12, 2003·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
May 23, 2003·Infection and Immunity·Johannes H M LevelsSander J H van Deventer
Jun 27, 2003·The Journal of Clinical Hypertension·William C Cushman
Sep 1, 1965·American Journal of Public Health and the Nation's Health·W B KANNELP M MCNAMARA
Sep 17, 2005·The American Journal of Medicine·Paul D SteinRonald E Olson
May 2, 2006·Obesity·Tracy Stecker, Shane Sparks
Aug 21, 2007·Lancet·Franz H MesserliEberhard Ritz
May 27, 2008·Clinical Pharmacology and Therapeutics·D M RodenD R Masys
Oct 24, 2008·The New England Journal of Medicine·Daniel I FeigRichard J Johnson
Apr 15, 2009·Circulation·Mark A HlatkyUNKNOWN American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Cou
Jun 22, 2010·Nature Genetics·Jian YangPeter M Visscher
May 10, 2011·Nature Genetics·Jian YangPeter M Visscher
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
May 3, 2012·Nature Reviews. Genetics·Peter B JensenSøren Brunak
Jun 19, 2012·Annual Review of Genomics and Human Genetics·Jen-Chyong WangAlison M Goate
Jun 19, 2012·Nature Genetics·Xiang Zhou, Matthew Stephens
Dec 28, 2012·Nature Methods·Olivier DelaneauJonathan Marchini
Jan 10, 2013·PLoS Computational Biology·Joshua C Denny
Feb 15, 2013·PLoS Genetics·Xiang ZhouMatthew Stephens
Jun 8, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Omri GottesmanUNKNOWN eMERGE Network
Jan 30, 2014·Nature Genetics·Jian YangAlkes L Price
Sep 13, 2014·Nutrients·Elmar AignerChristian Datz
Jul 25, 2015·Genetics·Daniel GianolaDaniel Sorensen
Aug 14, 2015·Current Epidemiology Reports·Jennifer A SmithSharon L R Kardia
Sep 29, 2015·Nature Genetics·Brendan Bulik-SullivanBenjamin M Neale
Oct 1, 2015·BMJ : British Medical Journal·Connor A EmdinKazem Rahimi
Oct 3, 2015·American Journal of Human Genetics·Bjarni J VilhjálmssonAlkes L Price
Dec 15, 2015·Current Epidemiology Reports·Brion S Maher
Feb 9, 2016·Nature Genetics·Alexander GusevBogdan Pasaniuc
May 31, 2016·Genetic Epidemiology·Arunabha MajumdarJohn S Witte
Aug 23, 2016·Nature Genetics·Shane McCarthyUNKNOWN Haplotype Reference Consortium

❮ Previous
Next ❯

Software Mentioned

STRUCTURE
GEMMA
SHAPEIT
SNPRelate
IMPUTE2
PheWAS
BSLMM
1000G
Michigan Imputation Server ( HRC

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.